Friess Associates LLC Bio Techne Corp Transaction History

Friess Associates LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$132.75 - $203.8 $18.8 Million - $28.9 Million	-141,786 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$144.9 - $165.58 $998,361 - $1.14 Million	-6,890 Reduced 4.63%	141,786 $21 Million
Q1 2018 May 15, 2018	BUY	$131.46 - $151.04 $518,083 - $595,248	3,941 Added 2.72%	148,676 $22.5 Million
Q4 2017 Feb 14, 2018	BUY	$121.17 - $134.75 $15,146 - $16,843	125 Added 0.09%	144,735 $18.8 Million
Q3 2017 Nov 14, 2017	BUY	$113.59 - $123.78 $16.4 Million - $17.9 Million	144,610	144,610 $17.5 Million

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.7B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Friess Associates LLC with notifications on news.